Kenya - English - Pharmacy and Poisons Board

beximco pharmaceuticals ltd. 19 dhanmondi r/a road no. 7 dhaka-1205 - al hydroxide + mg hydroxide + simethicone - suspension and effervescent granules for oral - al hydroxide 200mg/5ml + mg hydroxide 400mg/5ml +… - antacids with antiflatulents

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - cefuroxime axetil, quantity: 300.715 mg - tablet, film coated - excipient ingredients: crospovidone; croscarmellose sodium; calcium carbonate; calcium stearate; purified water; colloidal anhydrous silica; microcrystalline cellulose; sodium lauryl sulfate; titanium dioxide; hypromellose; propylene glycol; brilliant blue fcf aluminium lake - cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis. acute exacerbations of chronic bronchitis, or acute bronchitis. skin and skin structure infections for example, furunculosis, pyoderma and impetigo. acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - cefuroxime axetil, quantity: 601.43 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; calcium stearate; microcrystalline cellulose; sodium lauryl sulfate; purified water; calcium carbonate; croscarmellose sodium; titanium dioxide; hypromellose; propylene glycol; brilliant blue fcf aluminium lake - cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis. acute exacerbations of chronic bronchitis, or acute bronchitis. skin and skin structure infections for example, furunculosis, pyoderma and impetigo. acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

al-madina pharmaceuticals ltd. - amoxicillin - bolus - 500 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

al-madina pharmaceuticals ltd. - chlortetracycline hydrochloride - powder - 20 gm/100 gm

Bangladesh - English - DGDA (Directorate General of Drug Administration)

al-madina pharmaceuticals ltd. - doxycycline - powder - 100 mg/gm

Bangladesh - English - DGDA (Directorate General of Drug Administration)

al-madina pharmaceuticals ltd. - doxycycline + tylosin - powder - 20 gm + 23 gm/100 gm

Bangladesh - English - DGDA (Directorate General of Drug Administration)

al-madina pharmaceuticals ltd. - doxycycline + tylosin - powder - 100 mg + 200 mg/gm

Bangladesh - English - DGDA (Directorate General of Drug Administration)

al-madina pharmaceuticals ltd. - streptomycin + sulfadiazine + sulfadimidine + sulfapyridine - bolus - 250 mg + 1.583 gm + 1.583 gm + 1.583 gm

Bangladesh - English - DGDA (Directorate General of Drug Administration)

al-madina pharmaceuticals ltd. - sulphadiazine + sulphadimidine + sulphapyridine - bolus - 1.666 gm + 1.666 gm + 1.666 gm